Comparative inhalation toxicity of ethyltoluene isomers in rats and mice

Abstract

The C9 alkylbenzenes, composed mostly of ethyltoluenes and trimethylbenzenes, comprise 75–90% of the naphtha fraction of crude oil. Occupational and environmental exposure to C9 alkylbenzenes occur via inhalation. We conducted short-term inhalation studies on the ethyltoluene isomers (2-, 3- or 4-) to select one isomer for more comprehensive studies. Male Hsd:Sprague Dawley rats and female B6C3F1/N mice (n = 10) were exposed by nose-only inhalation to 2-, 3- or 4-ethyltoluene (0, 1000 or 2000 ppm) or cumene (a reference compound: 0, 500 or 1000 ppm) 3 h/day, 5 days/week, for 2 weeks. Clinical observations included abnormal gait and delayed righting reflex. Rats and mice exposed to 2000 ppm 2-ethyltoluene and mice exposed to 2000 ppm 4-ethyltoluene were euthanized early in moribund condition; no exposure-related deaths were observed with 3-ethyltoluene or cumene. Histopathology of selected tissues revealed that the nose and liver (rats and mice) and lung (mice only) to be toxicity targets. In the mouse lung, all compounds except 4-ethyltoluene produced bronchial and bronchiolar hyperplasia. In rats and mice, 2-ethyltoluene was the only compound to produce lesions in the nose and liver: in mice, squamous metaplasia and neutrophilic inflammation of the respiratory epithelium and atrophy and degeneration of the olfactory epithelium were observed in the nose and centrilobular hypertrophy and necrosis were observed in the liver. In rats, 2-ethyltoluene exposure produced atrophy of the olfactory epithelium in the nose and centrilobular necrosis in the liver. Based on mortality, body weight effects and histopathology, the 2-ethyltoluene isomer was the most potent isomer.

Keywords:

• Ethyltoluene
• C9 alkylbenzene
• nose-only inhalation
• naphtha
• inhalation toxicity
• CASRN 611-14-3
• CASRN 620-14-4
• CASRN 25550-14-5

Acknowledgements

This work was performed for the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, US Department of Health and Human Services, under the following contracts: No. HHSN291200775561C, No HHSN273201400027C, No. HHSN27320140020C, No. HHSN273201500012C. Prior to submission, this work was internally reviewed by Drs. G. Flake and M. Stout.

Disclosure statement

The authors declared no potential conflicts or interest with respect to the research, authorship and/or publication of this article.